Part of GSK Plc, Beecham Group Plc is a British company located in Middlesex. The firm functions as an investment holding company. It was founded in 1928.\nThe company says this about itself: The principal activity Of the Company is the holding of Intercompany bans and receipt Of interest. The Company had previously been an investment holding company. The Company is a member Of the GlaxoSmithKline Group (the 'Group\"). The directors do not envisage any change to the nature of the business in the future,

TNO is an independent research organization with approximately 3,000 employees. They believe in joint creation of value in social and economic terms. They focus on transitions or changes in five social themes: Industry, Healthy Living, Defense & Safety, Environment and Energy. Targeted innovation, which is what TNO stands. They develop knowledge not about knowledge, but about practical application.

Winston Laboratories, Inc. manufactures pharmaceutical products. It discovers, develops and commercializes therapeutics for pain. The company's proprietary technologies involve neuroactive compounds which affect the functioning of neurotransmitters. Winston Laboratories was founded by Joel E. Bernstein and is headquartered in Vernon Hills, IL.

Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.

Markets pharmaceutical specialties & personal products

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for the last 55 years. Since Bukwang was listed in the Korea Stock Exchange in 1988, Bukwang is proud to have kept a healthy financial status and stable track record that earned trust from its employees and shareholders. Bukwang’s operating profit is at the top of the rank in the industry, nearing 20% as of financial year 2014. Bukwang’s armamentarium consists of more than 100 products in various therapeutic areas: liver disease treatments such as Levovir and Legalon, diabetic complication products such as Dexid and Thioctacid, CNS disorder drugs including Lonasen, Ixel and Orfil, and respiratory disease treatments such as Azeptin and Asima. Bukwang continues to grow its original drug business through consistent focus on new drug development.

Elorac, Inc. is a privately owned, specialty pharmaceutical company engaged in the development and commercialization of novel products for dermatology, allergy and oncology. The Company markets dermatological products in the United States through its dedicated internal sales force. In addition to the newly acquired Heprotect compounds, Elorac’s development pipeline includes: naloxone lotion for treatment of pruritus accompanying cutaneous T-cell lymphoma, a product with orphan drug and fast-track designations from the U.S. Food and Drug Administration; cidoxepin, a highly potent histamine H1-receptor antagonist being developed for relief of chronic urticaria; and a once-weekly tablet for nodulocystic acne.

Xinjiang New Lvbao Pharmaceutical Co., Ltd., established on 2015-11-17, The business scope includes the processing and sales of Chinese herbal decoction pieces;Uyghur medicine research and development;Sales:building materials,hardware,Computers and Accessories,sporting goods,Planting and sales of Chinese herbal medicines,Acquisition and sales of agricultural products,Fashion Design,production and sales,Jade processing and sales,Import and export business of general goods and technology;Food production and sales;Production and sales of medical devices;Realtor.;Manufacturing of medical packaging materials

Manufactures pharmaceuticals

Researches on gen thereapy.

Sanzhu Fuer Pharmaceutical Co., Ltd., established on 1996-12-13, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Health food production;food production;Production of formula food for special medical purpose;Drug Wholesale;food sales;Do dropshipping.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Non-residential real estate leases;housing lease;property management;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chinese herbal medicine planting;Chinese herbal medicine acquisition;Wholesale of edible agricultural products;Retailing of Edible Agricultural Products;Primary processing of edible agricultural products;Production of Class I Medical Devices;Sales of hygiene products and single-use medical products;grain sales;Cosmetics Wholesale;Daily necessities sales;Home Appliance Sales;Conference and Exhibition Services;Import and export;Food import and export;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);total mass4.5Road freight transport of ordinary freight vehicles of 1 ton or less(Except network freight and dangerous goods).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

B.G. Negev Technologies Ltd. serves as the link between industry and academic research programs. It products and technology transfer to existing companies. The company was founded in 1978 and is headquartered in Beer Sheva, Israel.

Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. It focuses on different sectors such as cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin's, analgesic, and iron preparations. The company was founded in 1979 and is headquartered in Ahmedabad, India.

Hadasit is the technology transfer company of Hadassah Medical Center in Jerusalem. They transform the cutting-edge research coming out of Hadassah into marketable medical technologies. They turn ground-breaking ideas into viable products and services that can change the world and better humanity. For more than a century, Hadassah has set the standard of excellence for medical care and research in Israel. Their doctors and scientists are on the frontlines, uniquely positioned to pinpoint ever-evolving medical needs. Their experience and ingenuity has yielded new ideas with huge potential in all areas of medicine, including therapeutics, diagnostic medical devices, and digital health. More than half of all hospital research in Israel is conducted at Hadassah. Hadasit is Hadassah’s vehicle for commercialization of the intellectual property and R&D capabilities developed there. Hadasit holds exclusive rights to every innovation and invention emerging from Hadassah and they are dedicated to bringing these life-saving technologies to the general public.